EMAIL THIS PAGE TO A FRIEND

Chemical communications (Cambridge, England)

A luminescent nanoporous hybrid material based drug delivery system showing excellent theranostics potential for cancer.


PMID 23872783

Abstract

A novel hybrid nanoporous material (LNH-1) bearing a tris(propyliminomethyl)-phloroglucinol fluorescent moiety in the framework has been designed and administration of an LNH-1 based drug delivery system containing doxorubicin to cancer cells showed inhibition of proliferation, suggesting its future potential theranostics application in cancer.